Article

MARKETING ANALYSIS OF DRUGS USED FOR VIRAL HEPATITIS IN THE REPUBLIC OF UZBEKISTAN

Gulchexra MamatisakovaAziza TuxtayevaRano AlievaCandidate of Pharmaceutical Sciences, Dotcent, Tashkent Pharmaceutical Institute, Uzbekistan, Tashkent

Universum Medicine & pharmacologyjournal2021en

ABI

Abstract

An marketing analysis of hepatoprotectors of the Republic of Uzbekistan was carried out according to the State registers of medicines and medical devices No. 22 for 2018; No.23 for 2019; No24 for 2020 according to research. Medicines for the treatment of viral hepatitis. 2018-2019 of the total number of 28.7% is accounted for by domestic producers. The number of drugs for the treatment of viral hepatitis of domestic pharmaceutical manufacturers 2018-2020 increased from 30 to 31 positions.

Topics

Education, Innovation and Language Studies Economic and Industrial Development Economic, Social, and Public Health Issues in Russia and Globally

Identifiers

DOI: 10.32743/unimed.2021.78.6.11900

Citations and references

Cited by 00 references

Metrics — AkademScholar · Coming soon